Diastolic Dysfunction and Hypertension

Medical Clinics of North America

Volumn 101, Issue 1, 2017, Pages 7-17

  Nadruz, Wilson ^a,b   Shah, Amil M ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Diastolic dysfunction; Heart failure; Hypertension; Left ventricular hypertrophy

Indexed keywords

AGE DISTRIBUTION; AGING; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; ETHNIC DIFFERENCE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; SODIUM INTAKE; COMPLICATION; DIASTOLE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; SYSTOLE;

DIASTOLE; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84996605701     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2016.08.013     Document Type: Review

References (64)

1. 1 Verma, A., Solomon, S.D., Diastolic dysfunction as a link between hypertension and heart failure. Med Clin North Am 93 (2009), 647–664.
2. 2 Wan, S.H., Vogel, M.W., Chen, H.H., Pre-clinical diastolic dysfunction. J Am Coll Cardiol 63 (2014), 407–416.
3. 3 Redfield, M.M., Jacobsen, S.J., Burnett, J.C. Jr., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003), 194–202.
4. 4 Chobanian, A.V., Bakris, G.L., Black, H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003), 1206–1252.
5. 5 Shah, S.J., Kitzman, D.W., Borlaug, B.A., et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134 (2016), 73–90.
6. 6 Owan, T.E., Hodge, D.O., Herges, R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006), 251–259.
7. 7 Gaasch, W.H., Zile, M.R., Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55 (2004), 373–394.
8. 8 Kass, D.A., Bronzwaer, J.G., Paulus, W.J., What mechanisms underlie diastolic dysfunction in heart failure?. Circ Res 94 (2004), 1533–1542.
9. 9 Santos, A.B., Gupta, D.K., Bello, N.A., et al. Prehypertension is associated with abnormalities of cardiac structure and function in the atherosclerosis risk in communities study. Am J Hypertens 29 (2016), 568–574.
10. 10 Galderisi, M., Petrocelli, A., Alfieri, A., et al. Impact of ambulatory blood pressure on left ventricular diastolic dysfunction in uncomplicated arterial systemic hypertension. Am J Cardiol 77 (1996), 597–601.
11. 11 Oe, Y., Shimbo, D., Ishikawa, J., et al. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens 26 (2013), 808–815.
12. 12 Laurent, S., Boutouyrie, P., The structural factor of hypertension: large and small artery alterations. Circ Res 116 (2015), 1007–1021.
13. 13 Abhayaratna, W.P., Srikusalanukul, W., Budge, M.M., Aortic stiffness for the detection of preclinical left ventricular diastolic dysfunction: pulse wave velocity versus pulse pressure. J Hypertens 26 (2008), 758–764.
14. 14 Zhang, Y., Li, Y., Ding, F.H., et al. Cardiac structure and function in relation to central blood pressure components in Chinese. J Hypertens 29 (2011), 2462–2468.
15. 15 Zhang, Y., Kollias, G., Argyris, A.A., et al. Association of left ventricular diastolic dysfunction with 24-h aortic ambulatory blood pressure: the SAFAR study. J Hum Hypertens 29 (2015), 442–448.
16. 16 Rossi, G.P., Cesari, M., Cuspidi, C., et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 62 (2013), 62–69.
17. 17 Alpert, M.A., Omran, J., Mehra, A., et al. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 56 (2014), 391–400.
18. 18 London, G.M., Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16 (2003), 85–94.
19. 19 Janardhanan, R., Desai, A.S., Solomon, S.D., Therapeutic approaches to diastolic dysfunction. Curr Hypertens Rep 11 (2009), 283–291.
20. 20 Vlasseros, I., Katsi, V., Vyssoulis, G., et al. Aggravation of left ventricular diastolic dysfunction in hypertensives with coronary artery disease. Hypertens Res 36 (2013), 885–888.
21. 21 Escobar, E., Hypertension and coronary heart disease. J Hum Hypertens 16 (2002), S61–S63.
22. 22 Nagueh, S.F., Smiseth, O.A., Appleton, C.P., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (2016), 277–314.
23. 23 Nadruz, W., Myocardial remodeling in hypertension. J Hum Hypertens 29 (2015), 1–6.
24. 24 Dini, F.L., Galderisi, M., Nistri, S., et al. Abnormal left ventricular longitudinal function assessed by echocardiographic and tissue Doppler imaging is a powerful predictor of diastolic dysfunction in hypertensive patients: the SPHERE study. Int J Cardiol 168 (2013), 3351–3358.
25. 25 Santos, M., Shah, A.M., Alterations in cardiac structure and function in hypertension. Curr Hypertens Rep, 16, 2014, 428.
26. 26 Wachtell, K., Smith, G., Gerdts, E., et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 85 (2000), 466–472.
27. 27 Phillips, R.A., Goldman, M.E., Ardeljan, M., et al. Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol 14 (1989), 979–985.
28. 28 Fox, E.R., Taylor, J., Taylor, H., et al. Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J 153 (2007), 238–244.
29. 29 Chahal, N.S., Lim, T.K., Jain, P., et al. New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: a population study of hypertensive subjects. Eur Heart J 31 (2010), 588–594.
30. 30 Upadhya, B., Taffet, G.E., Cheng, C.P., et al. Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol 83 (2015), 73–87.
31. 31 Borlaug, B., Redfield, M., Melenovsky, V., et al. Longitudinal changes in left ventricular stiffness: a community-based study. Circ Heart Fail 6 (2013), 944–952.
32. 32 Sharp, A., Tapp, R., Francis, D.P., et al. Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol 52 (2008), 1015–1021.
33. 33 Kishi, S., Reis, J.P., Venkatesh, B.A., et al. Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Am Heart Assoc, 4, 2015, e001264.
34. 34 Langenfeld, M.R., Schobel, H., Veelken, R., et al. Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertension. Eur Heart J 19 (1998), 951–958.
35. 35 Hummel, S.L., Seymour, E.M., Brook, R.D., et al. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ Heart Fail 6 (2013), 1165–1171.
36. 36 Cwynar, M., Gąsowski, J., Stompór, T., et al. Blood pressure and arterial stiffness in patients with high sodium intake in relation to sodium handling and left ventricular diastolic dysfunction status. J Hum Hypertens 29 (2015), 583–591.
37. 37 Frohlich, E.D., Varagic, J., Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol 20 (2005), 424–429.
38. 38 de Simone, G., Izzo, R., De Luca, N., et al. Left ventricular geometry in obesity: is it what we expect?. Nutr Metab Cardiovasc Dis 23 (2013), 905–912.
39. 39 Grandi, A.M., Zanzi, P., Fachinetti, A., et al. Insulin and diastolic dysfunction in lean and obese hypertensives: genetic influence. Hypertension 34 (1999), 1208–1214.
40. 40 Leggio, M., Cruciani, G., Sgorbini, L., et al. Obesity-related adjunctive systo-diastolic ventricular dysfunction in patients with hypertension: echocardiographic assessment with tissue Doppler velocity and strain imaging. Hypertens Res 34 (2011), 468–473.
41. 41 Murarka, S., Movahed, M.R., Diabetic cardiomyopathy. J Card Fail 16 (2010), 971–979.
42. 42 Russo, C., Jin, Z., Homma, S., et al. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail 12 (2010), 454–461.
43. 43 Yang, Y., Wang, Y., Shi, Z.W., et al. Association of E/E’ and NT-proBNP with renal function in patients with essential hypertension. PLoS One, 8, 2013, e54513.
44. 44 Nardi, E., Cottone, S., Mulè, G., et al. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol 20 (2007), 320–328.
45. 45 Verdecchia, P., Schillaci, G., Guerrieri, M., et al. Prevalence and determinants of left ventricular filling abnormalities in an unselected hypertensive population. Eur Heart J 11 (1990), 679–691.
46. 46 de Simone, G., Kitzman, D.W., Chinali, M., et al. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the Hypergen study. Eur Heart J 26 (2005), 1039–1045.
47. 47 Zanchetti, A., Cuspidi, C., Comarella, L., et al. Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. J Hypertens 25 (2007), 2158–2167.
48. 48 Sciarretta, S., Paneni, F., Ciavarella, G.M., et al. Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fraction. Am J Hypertens 22 (2009), 437–443.
49. 49 Ballo, P., Nistri, S., Cameli, M., et al. Association of left ventricular longitudinal and circumferential systolic dysfunction with diastolic function in hypertension: a nonlinear analysis focused on the interplay with left ventricular geometry. J Card Fail 20 (2014), 110–120.
50. 50 Kalam, K., Otahal, P., Marwick, T.H., Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100 (2014), 1673–1680.
51. 51 Shah, A.M., Claggett, B., Sweitzer, N.K., et al. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132 (2015), 402–414.
52. 52 Shah, S.J., Aistrup, G.L., Gupta, D.K., et al. Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure. Am J Physiol Heart Circ Physiol 306 (2014), H88–H100.
53. 53 Galderisi, M., Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient. Am J Hypertens 24 (2011), 507–517.
54. 54 Schillaci, G., Pasqualini, L., Verdecchia, P., et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 39 (2002), 2005–2011.
55. 55 Wang, M., Yip, G.W., Wang, A.Y., et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 23 (2005), 183–191.
56. 56 Sharp, A.S., Tapp, R.J., Thom, S.A., et al. Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J 31 (2010), 747–752.
57. 57 Wachtell, K., Palmieri, V., Gerdts, E., et al. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study). Am J Cardiol 106 (2010), 999–1005.
58. 58 Peterson, G.E., de Backer, T., Contreras, G., et al. Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease. Hypertension 62 (2013), 518–525.
59. 59 Terpstra, W.F., May, J.F., Smit, A.J., et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens 19 (2001), 303–309.
60. 60 Muller-Brunotte, R., Kahan, T., Malmqvist, K., et al. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results from the Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA). Am J Hypertens 19 (2006), 927–936.
61. 61 Solomon, S.D., Verma, A., Desai, A., et al. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension 55 (2010), 241–248.
62. 62 Tapp, R.J., Sharp, A., Stanton, A.V., et al. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol 55 (2010), 1875–1881.
63. 63 Ikonomidis, I., Mazarakis, A., Papadopoulos, C., et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens 25 (2007), 439–447.
64. 64 Carluccio, E., Biagioli, P., Alunni, G., et al. Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. Eur Heart J 30 (2009), 1501–1509.